news.stocktradersdaily1d
How to Take Advantage of moves in (VKTX)
Check the time stamp on this data. Updated AI-Generated Signals for Viking Therapeutics Inc. (VKTX) available here: VKTX.
William Blair Issues Negative Outlook for VKTX Earnings
Equities researchers at William Blair decreased their Q1 2025 earnings per share estimates for shares of Viking Therapeutics in a research note issued to investors on Wednesday, February 5th. William ...
Hosted on MSN2d
Citigroup Initiates Coverage of Viking Therapeutics (VKTX) with Neutral Recommendation
Fintel reports that on February 7, 2025, Citigroup initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Neutral ...
Viking Therapeutics price target lowered to $96 from $109 at B. Riley
B. Riley lowered the firm’s price target on Viking Therapeutics (VKTX) to $96 from $109 and keeps a Buy rating on the shares. The firm remains ...
VKTX's Q4 Loss Wider Than Expected, Sales Nil, Stock Down 10%
Viking Therapeutics' fourth-quarter earnings miss estimates. The decline in stock price was attributable to a lack of material updates on its pipeline.
Investing14h
Viking Therapeutics Inc (VKTX)
On Thursday, Truist Securities reaffirmed its Buy rating and $120.00 price target for Viking Therapeutics (NASDAQ:VKTX) stock. The positive stance comes as competitor ...
Viking Therapeutics: Why The Oral VK2735 Phase 2 Readout Could Send The Stock Soaring
Viking Therapeutics is a clinical-stage biotech company focused on developing weight-loss therapies. Read why I rate VKTX ...
news.stocktradersdaily13d
(VKTX) Trading Advice
Trading Advice for Viking Therapeutics Inc. VKTX including day trading swing trading and long term investing plans for VKTX ...
Viking Therapeutics, Inc. (VKTX): One of January’s Biggest Losers
We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at ...